image

ISSN: 1935-1232 (P)

ISSN: 1941-2010 (E)

image
image

Abstract

Continued Interest in Developing Alpha-7 Nicotinic Agonist Drugs for Treating Cognitive Deficits in Patients with Schizophrenia

Author(s): Peter F. Buckley

EnVivo Pharmaceuticals has initiated a clinical safety study of an alpha-7 nicotinic agonist (EVP-6124) in twenty patientstreatedwith a second-generation antipsychotic medication. EVP-6124 is a potent full agonist at the alpha-7 nicotinic receptor.